Table 2

Profiling studies on PDAC tissues

miRNAs upregulated	miRNAs downregulated	References
miR-155, miR-181a, miR-181b, miR-181b-1, miR-181c,miR-181d, miR-21, miR-221	miR-148a, miR-148b,miR-375	39^§
miR-196a, miR-196b, miR-203, miR-210, miR-222	miR-216, miR-217, miR-375	22^§
miR-196a, miR-155, miR-143, miR-145, miR-223, miR-31	miR-96, miR-130b, miR-148a, miR-217, miR-375	27^§
miR-196a,miR-221, miR-222, miR-15b, miR-95, miR-186, miR-190, miR-200b		20
miR-155, miR-203, miR-210, miR-222	miR-216, miR-217	12^†
miR-21, miR-27a, miR-146a, miR-200a, miR-196a	miR-217,miR-20a, miR-96	26
miR-221, miR-181a, miR-181c, miR-155,miR-21, miR-100	miR-375	13
miR-21, miR-221, miR-100, miR-155, miR-181b,miR-196a		49
miR-21, miR-155, miR-210, miR-221, miR-222	miR-31, miR-122, miR-145, miR-146a	50
miR-223, miR-143, miR-27a, let-7i, miR-21, miR-145, miR-142-5p, miR-142-3p, miR-10a, miR-150, miR-214, miR-146b-5p, miR-107, miR-100, miR-23a, miR-199a-5p, miR-222, miR-103, miR-155, miR-221, miR-34a, miR-130a, miR-331-3p, miR-24, miR-505	miR-30d, miR-381, miR-29c, miR-324-3p, miR-874, miR-30a, miR-33b, miR-30c-1, miR-139-3p, miR-887, miR-141, miR-575, miR-28-3p, miR-665, miR-494, miR-617, miR-564, miR-148a, miR-130b, miR-217, miR-708, miR-648, miR-148b, miR-345, miR-216a	23^‡
miR-23a, miR-103, miR-107, miR-1207-5p, miR-125a-5p, miR-221, miR-140-5p, miR-143, let-7d, miR-146, miR-145, let-7e, miR-199b-3p, miR-199a -3p, miR-138-1, miR-92b, miR-29b-1, miR-92°, miR-181, miR-1246, miR-31, let-7,miR-155, miR-26a, miR-17, miR-23b, miR-24, miR-500*,miR-331-3p, miR-939	miR-1254,miR-559, let-7f-1*, miR-1274a	24
miR-132, miR-212		15
miR-372, miR-146a, miR-204, miR-10a, miR-10b		58
miR-21, miR-196a	miR-148a, miR-217	55§

§miRNA differently expressed between PDAC and chronic pancreatitis.
†18S rRNA expression was used as reference control.
‡Only the most 25 miRNA upregulated and downregulated are reported.
miRNA, microRNA; PDAC, pancreatic ductal adenocarcinoma.